Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Clinical trial NCT00004935 · TERMINATED
Trial details
- NCT number
- NCT00004935
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-30
- Primary completion
- 2014-11-06
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.